Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinomaARNOLD, J. M; HAGGARD, P. R; CUMMINGS, M et al.British journal of cancer. 2005, Vol 92, Num 11, pp 2024-2031, issn 0007-0920, 8 p.Article

Curcumin Enhances Oral Bioavailability and Anti-Tumor Therapeutic Efficacy of Paclitaxel upon Administration in Nanoemulsion FormulationGANTA, Srinivas; DEVALAPALLY, Harikrishna; AMIJI, Mansoor et al.Journal of pharmaceutical sciences. 2010, Vol 99, Num 11, pp 4630-4641, issn 0022-3549, 12 p.Article

Expression of aberrantly glycosylated Mucin-1 in ovarian cancerVAN ELSSEN, Catharina H. M. J; FRINGS, Peter W. H; BOT, Freek J et al.Histopathology. 2010, Vol 57, Num 4, pp 597-606, issn 0309-0167, 10 p.Article

Replication Protein A in Nonearly Ovarian Adenocarcinomas: Correlation With MCM-2, MCM-5, Ki-67 Index and Prognostic SignificanceLEVIDOU, Georgia; VENTOURI, Kiriaki; NONNI, Afroditi et al.International journal of gynecological pathology. 2012, Vol 31, Num 4, pp 319-327, issn 0277-1691, 9 p.Article

Angiogenesis and vascular survival ability in ovarian adenocarcinomasGIATROMANOLAKI, A; SIVRIDIS, E; TSIKOURAS, P et al.Virchows Archiv. 2004, Vol 445, Num 5, pp 521-526, issn 0945-6317, 6 p.Article

18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell linesCHUNG SOO LEE; JAE CHON YANG; YUN JEONG KIM et al.European journal of pharmacology. 2010, Vol 649, Num 1-3, pp 354-361, issn 0014-2999, 8 p.Article

Intratumoral lymphocyte density in serous ovarian carcinoma is superior to ERCC1 expression for predicting response to platinum-based therapyBÖSMÜLLER, Hans; HAITCHI-PETNEHAZY, Sophie; FEND, Falko et al.Virchows Archiv. 2011, Vol 459, Num 2, pp 183-191, issn 0945-6317, 9 p.Article

Expression and prognostic significance of cyclin D3 in ovarian adenocarcinomasLEVIDOU, Georgia; KORKOLOPOULOU, Penelope; THYMARA, Irene et al.International journal of gynecological pathology. 2007, Vol 26, Num 4, pp 410-417, issn 0277-1691, 8 p.Article

Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cellsYADAV, Sunita; VAN VIERKEN, Lilian E; LITTLE, Steven R et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 4, pp 711-722, issn 0344-5704, 12 p.Article

Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosisALI-FEHMI, Rouba; KHALIFEH, Ibrahim; BANDYOPADHYAY, Sudeshna et al.International journal of gynecological pathology. 2006, Vol 25, Num 3, pp 223-229, issn 0277-1691, 7 p.Article

Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours : relationship with cell cycle regulators and prognostic implicationsGAKIOPOULOU, H; KORKOLOPOULO, P; BAMIAS, A et al.British journal of cancer. 2007, Vol 97, Num 8, pp 1124-1134, issn 0007-0920, 11 p.Article